Third Harmonic Bio

Third Harmonic Bio is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for inflammatory diseases. Their primary focus is on advancing the next wave of medicine for dermal, respiratory, and gastrointestinal inflammatory diseases. They are grounded in their purpose of developing novel therapeutics to meaningfully improve the lives of the patients they serve. Their lead product candidate, THB335, is a potent, highly selective, oral small molecule KIT inhibitor, currently being evaluated in a Phase 1 clinical trial.

The company is driven to deliver value to patients, physicians, employees, and shareholders. They are currently focused on developing THB335 for the treatment of multiple mast cell-mediated inflammatory diseases, such as chronic urticaria and severe asthma. Third Harmonic Bio is led by an experienced executive team with a proven track record of success in the pharmaceutical industry. They are committed to advancing a targeted approach to mast cell-driven inflammation, offering hope for millions of people living with inflammatory diseases.

Third Harmonic Bio is a clinical-stage biopharmaceutical company dedicated to developing novel therapeutics for dermal, respiratory, and gastrointestinal inflammatory diseases. Their mission is to meaningfully improve the lives of patients by targeting mast cell-mediated inflammation through the inhibition of KIT, a key receptor involved in mast cell activation. They are currently focused on advancing their lead product candidate, THB335, a highly selective, oral small molecule wild-type KIT inhibitor, for the treatment of chronic urticaria, severe asthma, and other mast cell-mediated inflammatory diseases.

Third Harmonic Bio fosters a collaborative and driven culture, emphasizing teamwork and a shared passion for developing impactful medicines. They seek big-picture thinkers who are dedicated to building a successful company and improving the lives of their patients. The company's culture is described as "extraordinary" and emphasizes the unique opportunities for growth and development that exist within the organization.